Point-of-Care Infectious Disease Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Point-of-Care Infectious Disease Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.
Market Dynamics
Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.
Key features of the study:
This report provides in-depth analysis of point of care infectious disease diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market
Detailed Segmentation:
Global Point of Care Infectious Disease Diagnostics Market, By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Global Point of Care Infectious Disease Diagnostics Market, By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
Global Point of Care Infectious Disease Diagnostics Market, By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
Global Point of Care Infectious Disease Diagnostics Market, By Geography:
North America
By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
By Country:
U.S.
Canada
Europe
By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Danaher Corporation*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Abbott Laboratories
Acon Laboratories, Inc.
Hoffman-La Roche Ltd.
Becton, Dickinson, and Company
Trinity Biotech Plc
AccuBioTech Co., Ltd.
Cardinal Health, Inc.
“*” marked represents similar segmentation in other categories in the respective section.